Serological markers of natural immunity to Plasmodium falciparum infection
对恶性疟原虫感染的自然免疫的血清学标志物
基本信息
- 批准号:10301258
- 负责人:
- 金额:$ 18.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-12 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AllelesAnopheles GenusAntibodiesAntibody titer measurementAntigensB-LymphocytesBerryBindingBiological AssayBiteBloodBlood CirculationChildChildhoodClinicalClinical ImmunologyClinical ResearchCohort StudiesCollectionCommunicable DiseasesCulicidaeCustomDNADataData ScienceDatabasesDetectionDevelopmentDevelopment PlansDiseaseDoctor of MedicineEnrollmentEpitopesErythrocytesExposure toFundingGenerationsGenetic VariationGeographic LocationsGoalsHouseholdHumanHumoral ImmunitiesImmuneImmune responseImmune systemImmunityImmunodominant EpitopesImmunologyImpairmentIn VitroIndividualInfectionInternationalInvadedK-Series Research Career ProgramsLaboratoriesLeadLeadershipLiverMalariaMalaria VaccinesMalawiMarylandMasksMembrane ProteinsMentorsMentorshipMethodsMicroarray AnalysisMicrosatellite RepeatsModelingMolecular EpidemiologyNatural ImmunityOutcomeParasitesParticipantPeptidesPlasmodiumPlasmodium falciparumPlasmodium falciparum genomePositioning AttributeProteinsResearchResearch DesignResearch PersonnelRoleSalivary GlandsSamplingSerologySerumSourceSpecialistSporozoitesT-Lymphocyte EpitopesTestingTrainingTravelUnited States National Institutes of HealthUniversitiesVaccinesVariantWorkacquired immunitybasecareercareer developmentdesignepidemiology studyglobal healthhuman DNAimprovedin silicoin vitro Modelin vivoinsightinterestlarge datasetsmachine learning algorithmmalaria infectionmalaria mosquitomedical schoolsmembernovelnovel vaccinespathogenpolyclonal antibodypreventrandom forestresponseserological markerskillssurveillance datatooltranslational scientisttransmission processvaccine candidatevaccine developmentvaccinology
项目摘要
PROJECT SUMMARY
Plasmodium falciparum is the most common and deadly cause of malaria. An effective malaria vaccine has the
potential to make a pivotal change in malaria control and eradication. For a vaccine to contribute significantly to
malaria eradication, it must target the early, pre-erythrocytic part of the lifecycle to block both symptomatic
disease and asymptomatic infection, which perpetuates transmission. Naturally acquired immunity to pre-
erythrocytic infection is acquired with exposure but remains poorly understood and continues to impede vaccine
efforts. DeAnna Friedman-Klabanoff, M.D., a pediatric infectious disease specialist at the University of Maryland
School of Medicine, developed this career development award proposal to use novel high-throughput tools to
define naturally acquired humoral immunity to diverse pre-erythrocytic epitopes associated with protection, which
could lead to novel vaccine candidates. Dr. Friedman-Klabanoff’s long-term goal is to become an independent
clinical and translational researcher dedicated to the development of a malaria vaccine, applying immunology
and data science to inform and optimize vaccine development. To gain the skills necessary to achieve this goal,
Dr. Friedman-Klabanoff proposes a career development plan that includes mentoring from Drs. Miriam Laufer,
Shannon Takala Harrison, Michael Cummings, Andrea Berry, Kathleen Neuzil, and John Adams, leaders in the
fields of international research design and leadership, molecular epidemiology, data science for analysis of large
data sets, use of peptide microarrays to study malaria, vaccinology, and in vitro models of pre-erythrocytic
immunity. This project will utilize samples and data from a cohort study of malaria in Malawi led by Dr. Laufer,
the primary mentor for this proposal. Household members were followed monthly for detection of malaria
infection and mosquitoes were collected from the houses to identify bloodmeal sources. Bloodmeal sources will
be identified by matching the human DNA found in the mosquito bloodmeals to DNA from enrolled participants .
Mosquito salivary glands will also be tested for P. falciparum infection to determine if the mosquitoes were
infectious. Children will be defined as protected or infected based on whether they develop blood-stage infection
during the month after an infectious bite. Aim 1 of this proposal will be to identify serologic responses associated
with natural protection against P. falciparum infection after exposure to an infectious bite. Serum from the day of
exposure will be probed on a custom-developed peptide microarray designed from diverse, field-derived
sequences to characterize pre-exposure immunity to pre-erythrocytic antigens. Aim 2 of this proposal is to
assess the functional role of antibodies targeting P. falciparum pre-erythrocytic antigens of interest. B- and T-
cell epitope prediction tools will be used to find predicted epitopes in pre-erythrocytic proteins and their variants,
and in vitro liver models will be used to assess the functional role of antibodies to these epitopes to validate and
down select the potential epitopes. The practical implications of this work will be to identify promising epitopes
that are targets of protective immunity.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DeAnna Friedman-Klabanoff其他文献
DeAnna Friedman-Klabanoff的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DeAnna Friedman-Klabanoff', 18)}}的其他基金
Serological markers of natural immunity to Plasmodium falciparum infection
对恶性疟原虫感染的自然免疫的血清学标志物
- 批准号:
10448386 - 财政年份:2021
- 资助金额:
$ 18.91万 - 项目类别:
Serological markers of natural immunity to Plasmodium falciparum infection
对恶性疟原虫感染的自然免疫的血清学标志物
- 批准号:
10643851 - 财政年份:2021
- 资助金额:
$ 18.91万 - 项目类别:
Serological markers of natural immunity to Plasmodium falciparum infection
对恶性疟原虫感染的自然免疫的血清学标志物
- 批准号:
10882400 - 财政年份:2021
- 资助金额:
$ 18.91万 - 项目类别: